Health Catalyst (HCAT) logo

Health Catalyst (HCAT) stock

Healthcare data analytics , market cap $113M

After-hours
$1.45
+0.69%

Close $1.44 -4.64%

As of 5:04 PM ET after-hours, delayed 15+ min · Live for Pro members

Why is HCAT down?

Down 4.6% today, more than its software peers' 1.3%; no story names it yet.

Fell 16% since Oct 28

Down 16% from Oct 28 to Nov 9 while the S&P 500 fell 3%.

  • Its Nov 5 results: total revenue was $56.3M, from $76.3M a year before; adjusted gross profit was $24.9M, from $40.1M. It fell 3% on Nov 6.

Sources: Price history, Nov 9, 2026; Company release, Nov 5, 2026

Tell me next time HCAT moves

Free account, no card. An optional alert when HCAT moves or its score changes.

Or see it live, free until Thursday morning. No account.
1 more reason, free with an account →2 more reasons why HCAT fell 16% since Oct 28, from its filings, with the other side, the timeline, and its peers, for Pro members.
Quality Score
-8
Poor
In its industry
#259of 268
Checks firing
1of 14
Choppy
From 52-week high
-57.1%
under its best in a year

HCAT's Quality Score fell 2 points on Tue, Nov 10, to -8.

See HCAT's 14 chart checksSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Key facts on HCAT

Key facts on HCAT
Holding it backMoves 8.3% a day while sales shrink
Latest filing8-K, Nov 5 Reported its quarterly results
1 more reason behind HCAT's -8, free with an account →3 more reasons behind HCAT's -8, for Pro members.

HCAT in the news

TodayNo story names it yet.

HCAT catalysts

Coming up

After its last 4 reports it closed -11.7% on average, higher 1 of 4 times.

14 past catalysts since 2020, with sizes and sources, for Pro members.

Why HCAT scores -8

Poorfor quality, not price, 1 of 14 chart checks firingWhat the Quality Score means

-8 is below -5, off the left end of the scale.

  • −3Long-term trend below a falling 200-⁠day average, down over one year, down over two years
  • −2Growth sales down 14% on the year, operating margin down 36.5 pointsSales and margins against a year earlier: up to +3 for fast growth and widening margins, down to -2 when both shrink.
  • Chart checks adds
  • Size subtracts
  • Profit subtractsRead on the last four quarters against the four before, or the last full year where no quarters are filed.
  • Volatility subtractsA daily range of 5% or more with nothing behind it (no profit or cash flow, sales shrinking, or 10% more shares outstanding with no free cash flow): -1, or -2 from 8%.

No effect today: Run-up, Dilution, Cash flow, Persistence, News, and Insider trades.

What every line is worth, and the reason behind it, on HCAT and every other stock.Get in free →

Price, score, chart checks, and the industry rank are from a snapshot taken at 5:04 PM ET, at least 15 minutes behind. How we rank stocks.

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

How HCAT ranks in Software

HCAT is #259 of 268 by Quality Score.

How HCAT ranks in Software
RankStockQuality Score
259Health Catalyst (HCAT) logoHCATHealth Catalyst-8

More in Software

When does HCAT report earnings, and what happens after?

Expected to report Thu Mar 11, after the close (in 121 days).

What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.

What HCAT reported on Nov 5, 2026

The quarter

Sales of $56.3M, 26% less than a year ago; a profit of $0.53 a share, from a loss of $0.32.

“The net income generated during the three months ended September 30, 2026 was largely driven by a $65.9 million gain on sale of the Vitalware Business, while total revenue, gross profit, gross margin, Adjusted Gross Profit, Adjusted Gross Margin, and Adjusted EBITDA decreased year-over-year primarily as a result of the divestiture of the Vitalware Business on July 31, 2026 and headwinds related to the migration from DOS to Ignite, partially offset by our cost reduction initiatives.”

The quarter that ended Sep 30, from the company's press release

The press releaseThe filing on EDGAR

Where the sales came from

HCAT's results filing gives no sales by line in a table we read.

The outlook

The outlook the company gave, by period
MeasureFigure
Full year 2026
Total revenue$246M to $249Mkept

Figures as filed (SEC filing, Nov 5)

1 more outlook line, for Pro members.

The numbers

Market value
$113M
today
Sales
$272M
down 13.9% on the year
Free cash flow
$25.7M
last 12 months

Sales grew 11% a year over 5 years, fiscal 2020 to 2025.

Its share count grew 12% a year over 5 years.

5 more figures, for Pro members.

No analyst estimates on Breakaway: every figure here is filed.

The whole report on HCAT: every line of its sales, every outlook beside the one it replaced, and the company's words, for Pro members.

Close after the report, last 3

+7.3%-25.1%-2.7%
May 11Aug 6Nov 5
ReportedGapReaction5
days
Nov 5, 2026After close-2.7%-2.7%not yet
Aug 6, 2026After close-19.7%-25.1%-24.2%
May 11, 2026After close+5.8%+7.3%-8.0%

HCAT closed higher after 1 of its last 4 reports.

All 4 reports, and HCAT's Quality Score going into each

HCAT sales and profit by year

Sales and profit by year

Sales grew every year from 2018 to 2025, to $311M. It lost money in each of the eight years.

HCAT has 1 of 14 chart checks firing

Volume1 of 3 shown
Tight range1 of 3 shown
Buying1 of 3 shown
The other 10 checks on HCAT, and all 14 on every stock.Get in free →

HCAT RSI today: 38.4, below its 50-day and 200-day averages

Not scored

RSI 38.4, MACD below signal, below both averages. Not scored.

The deep dive on HCAT

7 more findings on HCAT, each with its source, for Pro members.

HCAT insider trades

One insider bought $105K across 1 filing in the last 6 months. No open-⁠market sales on record. The newest:

BuySimeon Kohl$105KChief Executive Officerat $1.79 on Sep 14, filed Sep 16

HCAT's officers and directors

Officers and directors with a Form 4 in the last 12 months.

5 more officers and directors file at HCAT.

See insider trades by person

Which ETFs hold HCAT?

In ETFs: HCAT is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.

About Health Catalyst

Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platform, analytics applications and support services and generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

1,200 employeesSouth Jordan, UThealthcatalyst.com

What Health Catalyst says it competes with

“We have experienced, and expect to continue to experience, intense competition from a number of companies.”

From its annual report, SEC filing · Mar 12, 2026

Here is what Pro members see.

  • The same page for Pro members, on Microsoft

    Its Quality Score and rank, the line that drives it, and the live price.

  • The full chart

    A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.

  • Every line of the score

    Price action, the company, and signals, each with its points, on HCAT and every other stock.

  • CEOs buying their own stock

    Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.

  • Congress trades

    A member's trades, newest first, each with its amount. Sort and filter the whole list.

  • 14 chart checks, read for you

    The ones firing on the stock, each in plain words, its rule a tap away.

  • Earnings, week by week

    Who reports each day, and how each stock took its last four reports.

  • FDA dates, counted down

    Each date in the company's words, its cash against the date, and an optional alert before it.

  • The market map

    Every stock a box, colored by its Quality Score.

  • Themes, ranked live

    Each theme's stocks ranked by Quality Score, live. Here, AI chips.

  • The top 10, every day

    The ten highest Quality Scores at each close, kept day by day, week by week.

  • Optional alerts, your way

    Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.

  • Your watchlist, scored

    Your stocks by Quality Score, today's move, or name.

  • On your phone and your laptop

    The same account and watchlist on both, each laid out for its screen.

  • Prices refresh every 2.5 seconds during market hours.
  • Optional alerts by push, email, or the bell.
  • Add it to your Home Screen and it opens like an app.

Pro members see every line of every stock's score.

  • What would turn HCAT's score around: 7 things
  • 2 more filings explained, a plain line each
  • Real-⁠time prices, no delay
BreakawaySep 16Simeon Kohl bought HCAT$105K at $1.79, filed Sep 16

Alerts are optional.

See HCAT's 14 chart checks

See it live, free until Thursday morning. No account. No card. Then keep going with a free account.

Straight AnswersStraight Answers

As of Nov 10, 2026: HCAT's Quality Score is -8 (Poor), #259 of 268 in Software. Insiders bought $105K in the last 6 months (Form 4).

What does HCAT's Quality Score say?

HCAT scores -8 today, which Breakaway calls Poor. It is #259 of 268 in Software by Quality Score, with 1 of 14 chart checks firing. Down 16% from Oct 28 to Nov 9 while the S&P 500 fell 3%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is HCAT's Quality Score?

HCAT scores -8 today, which Breakaway calls Poor (below zero). That is #259 of 268 in Software by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind HCAT's -8.

Are insiders buying HCAT?

One insider bought $105K across 1 filing in the last 6 months. No open-⁠market sales on record. The newest is Simeon Kohl, Chief Executive Officer, who bought $105K on Sep 14.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.

Every US stock, ranked live.

Insider and Congress trades, the chart, and the financials, in one score.

See all 3,168 stocks ranked

See it live, free until Thursday morning. No account. No card. Then keep going with a free account.

The moves after past earnings reports are past behavior, not a forecast.

The price, the score, the chart checks and readings, and the industry rank on this page are delayed at least 15 minutes.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs. Recorded live since Sep 9, 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.